Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia.
Blood Cells Mol Dis. 2012 Jan 15;48(1):17-21. doi: 10.1016/j.bcmd.2011.10.002. Epub 2011 Nov 12.
The alpha haemoglobin stabilising protein (AHSP) acts as a molecular chaperone for α-globin by stabilising nascent α-globin before transferring it to waiting free β-globin chains. Binding of AHSP to α-globin renders α-globin chemically inert whereby preventing it from precipitating and forming reactive oxygen species byproducts. The AHSP has been actively studied in the recent years, particularly in its relation to β-thalassaemia. Studies have shown that AHSP is a modifier in β-thalassaemia mice models. However, this relationship is less established in humans. Studies by some groups showed no correlation between the AHSP haplotypes and the severity of β-thalassaemia, whereas others have shown that certain AHSP haplotype could modify the phenotype of β-thalassaemia intermedia patients. We investigated the expression of AHSP in relation to selected demographic data, full blood count, HPLC results, HbE/β-thalassaemia genotype, Xmn-1 Gγ polymorphism, α-globin, β-globin and γ-globin expression. We found that AHSP expression was significantly correlated to mean cell haemoglobin level, HbF %, α-globin, β-globin and excess α-globin expression. We concluded that AHSP could be a secondary compensatory mechanism in red blood cells to counterbalance the excess α-globin chains in HbE/β-thalassaemia individuals.
α 珠蛋白稳定蛋白(AHSP)通过稳定新生的α 珠蛋白,然后将其转移到等待的游离β 珠蛋白链上,从而作为α 珠蛋白的分子伴侣。AHSP 与α 珠蛋白的结合使α 珠蛋白在化学上惰性,从而防止其沉淀并形成活性氧副产物。近年来,AHSP 一直受到广泛研究,尤其是在其与β 地中海贫血的关系方面。研究表明,AHSP 是β 地中海贫血小鼠模型的修饰因子。然而,这种关系在人类中尚未得到充分确立。一些研究小组的研究表明,AHSP 单倍型与β 地中海贫血的严重程度之间没有相关性,而另一些研究则表明,某些 AHSP 单倍型可以修饰中间型β 地中海贫血患者的表型。我们研究了 AHSP 的表达与选定的人口统计学数据、全血细胞计数、HPLC 结果、HbE/β-地中海贫血基因型、Xmn-1 Gγ 多态性、α-珠蛋白、β-珠蛋白和γ-珠蛋白表达之间的关系。我们发现 AHSP 的表达与平均细胞血红蛋白水平、HbF%、α-珠蛋白、β-珠蛋白和过量α-珠蛋白表达显著相关。我们得出结论,AHSP 可能是红细胞中的二级代偿机制,以平衡 HbE/β-地中海贫血个体中过量的α-珠蛋白链。